The explosive eruption of this stratovolcano, situated along a volcanic island arc at the subduction zone of the Indo-Australian plate, ejected huge amounts of rock, ash and pumice and was heard thousands of miles away.
Byetta and Bydureon are injectable drug pens used to control blood sugar in people with Type 2 diabetes. They are linked to pancreatitis and pancreatic cancer, which have led to lawsuits. Byetta (exenatide injection) is a twice-daily injectable drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of Type 2 diabetes. The drug is designed to work with diet and exercise to control blood sugar. Manufactured by San Diego-based Amylin Pharmaceuticals, Byetta was approved by the FDA in 2005.
basal-bolus insulin therapy. An insulin regimen for diabetic patients in which patients use short- or rapid-acting insulins before each meal (bolus doses) and a long-acting insulin once a day (basal dose). A typical regimen uses approximately equal doses of long-acting insulin (such as glargine) and short- or rapid-acting insulins.